Bevacizumab for Macular Serous Neuroretinal Detachment in Tilted Disk Syndrome

Abstract EN

Background.

Tilted disc syndrome (TDS) is a congenital anomaly characterized by “tilting” of the optic disc tipycally associated with myopic astigmatism, visual field defect, inferior staphyloma, and retinal pigment epithelium atrophy.

Associated complications such as macular serous neuroretinal detachment are well described; however, ideal therapy for such complication is unknown.

Methods.

One interventional case report is hereby described.

A patient affected by macular serous neuroretinal detachment-complicated tilted disk syndrome underwent a complete ophthalmic examination.

Optical coherence tomography and fluorescein angiography were taken at baseline and at scheduled visits.

Two intravitreal treatments of bevacizumab (avastin, 1.25 mg/0.05 mL) were performed at monthly interval.

Results.

At scheduled visit, one month after the second injection, OCT depicted persistence of neuroretinal detachment.

Best-corrected visual acuity remain stable as well as metamorphopsia and functional discomfort.

Conclusion.

Clinical evidence of this brief interventional case report indicates that one patient affected by recent serous macular detachment-complicated TDS did not benefit from 2 consecutive monthly intravitreal Avastin treatments.

Best-corrected visual acuity remained stable over a total observation period of 6 months.